C. Sanders

发表

A. Butt, K. Aldridge, C. Sanders, 2004, The Lancet. Infectious diseases.

Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations

K. Aldridge, C. Sanders, A. Janney, 1985, Antimicrobial Agents and Chemotherapy.

Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum.

K. Aldridge, C. Sanders, G. Valainis, 1988, Diagnostic microbiology and infectious disease.

Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak.

C. Sanders, J. Sanford, J. Luby, 1970, Annals of internal medicine.

Green monkey disease ("Marburg virus" disease): a new zoonosis.

C. Sanders, J. Luby, 1969, Annals of internal medicine.

Vibrio vulnificus infection: Case report and update since 1970

C. Sanders, L. G. Wickboldt, 1983 .

A 59-YEAR-OLD WOMAN WITH SHORTNESS OF BREATH: HYPERTROPHIC CARDIOMYOPATHY MASQUERADING AS CRITICAL AORTIC STENOSIS IN A PATIENT WITH BICUSPID AORTIC VALVE

W. Roberts, Q. Chu, G. Berenson, 2018 .

Cutaneous Tuberculosis

C. Sanders, M. Hill, 2017 .

Dermatologic infections in the immunocompromised (non-HIV) host.

C. Sanders, F. Lopez, 2001, Infectious disease clinics of North America.

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

R. Wallace,, C. Sanders, D. Graham, 1990, Antimicrobial Agents and Chemotherapy.

Prosthetic valve endocarditis due to Mycobacterium chelonei.

C. Sanders, J. Seabury, F. Repath, 1976, Southern medical journal.

ARTICLES FOR CONTINUING MEDICAL EDUCATION CLINICAL CASE OF THE MONTH Severe Progressive Weakness in a 58-Year-Old Man CARDIOLOGY REPORT Congenitally Bicuspid Aortic Valves in Adults

H. Hanley, G. Berenson, C. Sanders, 2003 .

Postoperative Fever of Unknown Origin

C. Sanders, F. Lopez, T. Jagneaux, 2007 .

AGENTS CHEMOTHER . resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei

R. Wallace,, C. Sanders, B. Brown, 2022 .

Mycobacterium marinum infections. A problem of recognition, not therapy?

C. Sanders, J. W. Brown, 1987, Archives of internal medicine.

In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline.

C. Sanders, J. R. Torres, M. Sands, 1978, Tubercle.

Cefamandole and cefoxitin.

R. Marier, C. Sanders, R. Greenberg, 1985, Annals of internal medicine.

Bacteremia Due to Bacteroides fragilis Group: Distribution of Species, β-Lactamase Production, and Antimicrobial Susceptibility Patterns

K. Aldridge, C. Sanders, D. Ashcraft, 2003, Antimicrobial Agents and Chemotherapy.

Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited.

D. Musher, C. Sanders, R. Hamill, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current antimicrobial therapy of anaerobic infections

K. Aldridge, C. Sanders, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

A multicenter study of the prevalence and susceptibility patterns of isolates of Streptococcus pneumoniae with reduced susceptibility to penicillin G in Louisiana.

P. O'cain, K. Aldridge, C. Sanders, 1998, The American journal of the medical sciences.

Skin and soft tissue infections in critical care.

C. Sanders, M. Hill, 1998, Critical care clinics.

18 – Anaerobic Infections of the Urinary Tract

C. Sanders, G. Risi, 1989 .

Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin-sulbactam, cefoxitin, imipenem, and metronidazole.

K. Aldridge, C. Sanders, 2002, Anaerobe.

Antimicrobial Therapy of Anaerobic Infections, 1991

K. Aldridge, C. Sanders, Kenneth E. Aldridge, 1991, Pharmacotherapy.

Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash.

C. Sanders, F. Lopez, Charles V. Sanders, 2001, Transactions of the American Clinical and Climatological Association.

Suppression of interferon response in lymphocytes from patients with uremia.

C. Sanders, A. Hull, J. Sanford, 1971, The Journal of laboratory and clinical medicine.

Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections.

E. Slaven, C. Sanders, F. Lopez, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Unusual manifestations of invasive pneumococcal infection.

C. Sanders, S. Taylor, Stephanie N. Taylor, 1999, The American journal of medicine.

Apparent ketoconazole failure in candidal cholecystitis.

B. J. Brooks, R. Marier, C. Sanders, 1982, Archives of internal medicine.

Candidal suppurative peripheral thrombophlebitis.

C. Stratton, C. Sanders, H. Hawley, 1982, Annals of internal medicine.

Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species

R. Marier, K. Aldridge, C. Sanders, 1984, Antimicrobial Agents and Chemotherapy.

Intravenous metronidazole therapy for Bacteroides fragilis meningitis.

L. J. Huffman, C. Sanders, C. Bryan, 1979, Southern medical journal.

Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates

K. Aldridge, C. Sanders, Charles V. Sanders, 1987, Journal of clinical microbiology.

Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates

K. Aldridge, C. Sanders, D. Schiro, 1990, Journal of clinical microbiology.

Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.

R. Marier, K. Aldridge, C. Sanders, 1983, Journal of medical microbiology.

N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria

R. Marier, C. Sanders, D. A. Martin, 1982, Antimicrobial Agents and Chemotherapy.

Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates

K. Aldridge, C. Sanders, 1987, Journal of clinical microbiology.

Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology

K. Aldridge, C. Sanders, S. Finegold, 1990, Antimicrobial Agents and Chemotherapy.

Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.

C. Stratton, K. Aldridge, C. Sanders, 1990, Diagnostic microbiology and infectious disease.

Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems

R. Marier, K. Aldridge, C. Sanders, 1983, Journal of clinical microbiology.

Moxalactam in the therapy of serious infections

R. Marier, K. Aldridge, C. Sanders, 1982, Antimicrobial Agents and Chemotherapy.

Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.

C. Stratton, K. Aldridge, C. Sanders, 1989, Diagnostic microbiology and infectious disease.

In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.

R. Marier, K. Aldridge, C. Sanders, 1984, Diagnostic microbiology and infectious disease.

Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.

K. Aldridge, C. Sanders, A. Janney, 1989, Diagnostic microbiology and infectious disease.

Presumed blastomycosis endophthalmitis.

C. Sanders, L. Joffe, R. Franklin, 1982, Annals of ophthalmology.

Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure.

R. Marier, C. Sanders, R. Greenberg, 1981, The American journal of medicine.

Fever and Rash in Critical Care

C. Sanders, L. Engel, F. Lopez, 2009 .

Allergic bronchopulmonary disease caused by Bipolaris hawaiiensis presenting as a necrotizing pneumonia: case report and review of literature.

C. Sanders, R. Saenz, W. D. Brown, 2001, The American journal of the medical sciences.

Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement.

C. Sanders, J. Nadell, J. W. Brown, 1976, Southern medical journal.

Systemic lupus erythematosus complicated by necrotizing fasciitis

C. Sanders, J. Angulo, E. Méndez, 1999, Lupus.

A. Butt, K. Aldridge, C. Sanders, 2004, The Lancet. Infectious diseases.

Cat-scratch disease causing reversible encephalopathy.

F. W. Black, C. Sanders, R. Strub, 1978, JAMA.

Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.

K. Aldridge, C. Sanders, A. Henderberg, 1989, Diagnostic microbiology and infectious disease.

Chronic postrheumatic-fever (Jaccoud's) arthritis. Case report with the rheumatoid factor and a family history of rheumatoid arthritis.

C. Sanders, C. Burda, 1967, Archives of internal medicine.

Fusobacterium necrophorum Sepsis With Cerebral Infarction

K. Aldridge, C. Sanders, C. Spencer, 1989, Southern medical journal.

Anaerobic disease of the lung.

C. Sanders, M. Hill, 1991, Infectious disease clinics of North America.

RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenem.

K. Aldridge, C. Sanders, D. Schiro, 1987, Diagnostic microbiology and infectious disease.

Microbiologic study of wound infections in tornado casualties.

D. Gilbert, C. Sanders, J. Sanford, 1973, Archives of environmental health.

Principles of antimicrobial therapy for head and neck infections.

C. Sanders, M. Hill, 1988, Infectious disease clinics of North America.

Cefamandole Therapy in Anaerobic Infections

C. Sanders, A. Lewis, Richard N. Greenberg, 1979, Antimicrobial Agents and Chemotherapy.

Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women.

R. Marier, D. Martin, K. Aldridge, 1985, The American journal of medicine.

Moxalactam intheTherapy ofSerious Infections

R. Marier, C. Sanders, A. Janney, 1982 .

Changing Trends in the Antimicrobial Susceptibility Pattern of Anaerobic Bacteria

C. Sanders, L. Ac, 1980 .

Methicillin Hemorrhagic Cystitis

D. Gilbert, C. Sanders, R. Bracis, 1977, Antimicrobial Agents and Chemotherapy.

A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

Jerome J. Schentag, G. Bernard, R. Greenman, 1991 .

Human Immunodeficiency Virus: Risk of Exposure Among Health Care Workers at a Southern Urban Hospital

C. Sanders, G. Risi, R. Gaumer, 1989, Southern medical journal.

Comparison of rapid identification assays for Staphylococcus aureus

R. Marier, K. Aldridge, C. Sanders, 1984, Journal of clinical microbiology.

Christmas treat to chronic cough.

C. Sanders, L. Engel, A. Zieske, 2011, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Christmas Treat to Chronic Cough CLINICAL CASE OF THE MONTH

C. Sanders, L. Engel, A. Zieske, 2011 .

Analysis of 106 cases of tularemia.

C. Sanders, R. Hahn, 1968, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Listeriosis as an Obstetric Complication in an Immunocompromised Patient

C. Sanders, F. Janney, J. Pastorek, 1989, Southern medical journal.

Trinity River serologic survey. A survey of residents of communities along the course of the Trinity River between Houston and Dallas, Texas, for antibodies to the viruses of St. Louis encephalitis, western equine encephalitis and California encephalitis.

C. Sanders, J. Sanford, J. Luby, 1971, American journal of epidemiology.

Posterior chest wall pulsation in congenital complete absence of the left pericardium.

D. Glancy, C. Sanders, A. Porta, 1974, Chest.

Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

R. Marier, K. Aldridge, C. Sanders, 1986, The Journal of antimicrobial chemotherapy.

Leptospiral pneumonia.

C. Sanders, M. Hill, 1997, Seminars in respiratory infections.

Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone.

K. Aldridge, C. Sanders, R. Saenz, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Localized and systemic infection due to Vibrio species.

C. Sanders, M. Hill, 1987, Infectious disease clinics of North America.

Ulcer of the hard palate.

B. J. Brooks, R. Marier, C. Sanders, 1982, JAMA.

Clinical Case of the Month: A 64 Year-Old Woman Presenting With Fever, Confusion, Ophthalmoplegia and Pneumonia.

C. Sanders, F. Lopez, R. Coleman, 2016, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use.

S. Lata, C. Sanders, L. Espinoza, 2011, Seminars in arthritis and rheumatism.

Southern Society for Clinical Investigation Founders’ Medal Acceptance

C. Sanders, 2008 .

The genital mycoplasmas.

C. Sanders, G. Risi, 1989, Obstetrics and gynecology clinics of North America.

An update on management of persons with human immunodeficiency virus and acquired immunodeficiency syndrome: introduction to symposium.

C. Sanders, R. Clark, 2004, American Journal of the Medical Sciences.

Faculty Evaluations by Medicine Residents Using Known versus Anonymous Systems

S. Chauvin, C. Sanders, C. Hilton, 2005, Medical education online.

Microbiologic and antibiotic aspects of infections in the oral and maxillofacial region.

R. Marier, J. Kent, C. Sanders, 1979, Journal of oral surgery.

Use of Single-Agent Antimicrobial Therapy in the Treatment of Polymicrobial Female Pelvic Infections

K. Aldridge, C. Sanders, S. Faro, 1982, Obstetrics and gynecology.

Hurricane Katrina and the LSU-New Orleans Department of Medicine: impact and lessons learned.

C. Sanders, 2006, The American journal of the medical sciences.

Piperacillin v Carbenicillin in the therapy for serious infections.

R. Marier, K. Aldridge, C. Sanders, 1982, Archives of internal medicine.

Susceptibility patterns of bacteria following therapy with piperacillin.

J. Mitchell, R. Marier, A. Marinaccio, 1982, The Journal of antimicrobial chemotherapy.

Interferon assays and quantitative virus determinations in a fatal infection in man with western equine encephalomyelitis virus.

C. Sanders, J. Luby, S. Sulkin, 1971, The American journal of tropical medicine and hygiene.

Antibiotic therapy for postcesarean endomyometritis.

C. Sanders, J. Pastorek, 1991, Reviews of infectious diseases.

Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074

K. Aldridge, C. Sanders, D. Schiro, 1987, European Journal of Clinical Microbiology.

Variation in the potentiation of β-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria

R. Marier, K. Aldridge, C. Sanders, 1986 .

Comparative in vitro activity of the new oral cephalosporin BMY-28100

K. Aldridge, C. Sanders, D. Schiro, 1987, European Journal of Clinical Microbiology.

Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: A review

C. Sanders, Charles V. Sanders, 1994, Intensive Care Medicine.

Vancomycin concentration in human tissues--preliminary report.

C. Sanders, J. R. Torres, A. Lewis, 1979, The Journal of antimicrobial chemotherapy.

Accidental administration of hepatitis B immune globulin to a patient positive for hepatitis B surface antigen.

C. Sanders, S. Leech, F. Bentley, 1985, Annals of allergy.

Diagnostic Approach to Rash and Fever in the Critical Care Unit

C. Sanders, L. Engel, F. Lopez, 2020 .

a 64-y ear-old w oman with shortness of Breath

J. Shellito, C. Sanders, F. Lopez, 2009 .

A middle-aged man with newly diagnosed HIV infection and rash.

C. Sanders, L. Nesbitt, F. Lopez, 2007, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.

R. Marier, K. Aldridge, C. Sanders, 1983, The Journal of antimicrobial chemotherapy.

Drug fever during treatment of pulmonary edema.

C. Sanders, A. Jain, F. Nicolle, 1982, Southern medical journal.

Metronidazole in the treatment of anaerobic infections.

C. Sanders, A. Lewis, B. Hanna, 1979, The American review of respiratory disease.

A multicenter study of the prevalence and susceptibility patterns of isolates of Streptococcus pneumoniae with reduced susceptibility to penicillin G in Louisiana.

K. Aldridge, C. Sanders, R. Silberman, 1998, The American journal of the medical sciences.